Speaker illustration

Professor Carolyn Sp Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)

Member of:

Heart Failure Association

Dr Lam is recognized globally for expertise in heart failure with mildly reduced and preserved ejection fraction. She is a world-renown clinical trialist, contributing in global leadership capacity to several heart failure trials that have changed practice in the field. Dr. Lam’s leadership in the field is recognized in her appointment to the 2021 ESC Heart Failure Guidelines Task Force and as International Honorary Fellow of the Heart Failure Society of America 2021. Her accomplishments are also recognized in numerous awards and grants: She is a recipient of the NMRC Senior Investigator Clinician Scientist Award, Founding Programme Lead of A*STaR’s Asian neTwork for Translational Research and Cardiovascular Trials (ATTRaCT), a Clarivate Highly Cited Researcher 2021 in Clinical Medicine and lead author of the chapter on HFpEF for Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 12th Edition. She serves as Associate Editor for Circulation and Eur J Heart Fail.

Guidelines in Practice: 2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Event: ESC Congress 2023

Topic: Chronic Heart Failure

Session type: New ESC Guidelines

Thumbnail

Implementing heart failure guidelines with collaborative care

Event: ESC Congress 2023

Topic: Chronic Heart Failure

Session type: Satellite Symposium

Thumbnail

Treating patients living with heart failure: are we really doing enough?

Event: ESC Congress 2023

Topic: Treatment

Session type: Satellite Symposium

Thumbnail

Ask the Trialists from Hot Line 2

Event: ESC Congress 2023

Topic: European Society of Cardiology

Session type: Ask the Trialists

Thumbnail

IV iron: the story so far

Event: Heart Failure 2023

Topic: Chronic Heart Failure

Session type: Satellite Symposium

Thumbnail

Putting the heart failure experts on the spot: what's new and noteworthy?

Event: Heart Failure 2023

Topic: Acute Heart Failure

Session type: Satellite Symposium

Thumbnail

Improving the protection of patients following a worsening HF event

Event: Heart Failure 2023

Topic: Chronic Heart Failure

Session type: Satellite Symposium

Thumbnail

State of the art: are HFpEF phenotypes, a needed classification?

Event: Heart Failure 2023

Topic: Chronic Heart Failure

Session type: Symposium

Thumbnail

e-Cardiology/Digital Health

Event: ESC Asia 2022 with APSC & AFC

Topic: e-Cardiology/Digital Health

Session type: Moderated Posters

Thumbnail

Hot Line: Heart Failure

Event: ESC Asia 2022 with APSC & AFC

Topic: Chronic Heart Failure

Session type: Hot Line

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb